R. Largillier

Prognostic factors in 1038 women with metastatic breast cancer

R. Largillier, Jean-­Marc Ferrero, J. Doyen et al. · Annals of Oncology · 2008 · 380 citations · Full text

Medicine, Biostatistics, Oncology +14

Multicentre, phase II study evaluating capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer

P. Fumoleau, R. Largillier, Christine Clippe et al. · European Journal of Cancer · 2003 · 307 citations

Medicine, Oncology, Pharmacology +16

BAYPAN study: a double-blind phase III randomized trial comparing gemcitabine plus sorafenib and gemcitabine plus placebo in patients with advanced pancreatic cancer

Anthony Gonçalvès, Marine Gilabert, E. François et al. · Annals of Oncology · 2012 · 214 citations · Full text

Medicine, Oncology, Pharmacology +7

Imaging in Evaluation of Response to Neoadjuvant Breast Cancer Treatment Benefits of MRI

C. Balu–Maestro, C. Chapellier, A. Bleuse et al. · Breast Cancer Research and Treatment · 2002 · 190 citations

Medicine, Oncology, Radiology +12

Final overall survival results of phase III GCIG CALYPSO trial of pegylated liposomal doxorubicin and carboplatin vs paclitaxel and carboplatin in platinum-sensitive ovarian cancer patients

Uwe Wagner, Christian Marth, R. Largillier et al. · British Journal of Cancer · 2012 · 186 citations · Full text

Medicine, Oncology, Pharmacology +17